Group financial statement for first half of 2008

 | Source: Novonesis (Novozymes A/S) Novonesis (Novozymes A/S) 

High sales growth in the first half year
Halfway into 2008, sales growth has remained high within both enzymes and
microorganisms, totaling 16% in local currencies (LCY). Earnings for the period
are satisfactory, despite low realized exchange rates and high raw material
prices. Full-year sales growth and earnings in LCY are now expected to be at
the upper end of the previously published range. In addition, expectations in
DKK are being increased on the basis of the current exchange rate level. 

Read the full company announcement

Attachments

koncernregnskab_q208_us.pdf
GlobeNewswire

Recommended Reading